FDA Approved: NIKKI — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals’ supplemental application for NIKKI, a combined oral contraceptive containing drospirenone and ethinyl estradiol.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contraception

Drugs mentioned

• NIKKI (DROSPIRENONE AND ETHINYL ESTRADIOL)

Snippet

SUPPL AP for NIKKI (DROSPIRENONE AND ETHINYL ESTRADIOL)